TickerFacts.

Oncolytics Biotech Inc (ONCY): Shareholders' Equity

Annual figures by period end, from SEC filings.

-$3.80M
As of 2025-12-31
-$6.17M
As of 2026-06-30
$3.30M2024-12-31: $3.30M2025-12-31: -$3.80M-$3.80M
2024-12-31 Shareholders' Equity (USD) 2025-12-31
Period endedShareholders' EquityChange YoYSource filing
2025-12-31-$3.80Mn/m2026-03-30, Balance as of period end
2024-12-31$3.30Mn/a2026-03-30, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShareholders' EquityChange YoY
Oncolytics Biotech Inc (ONCY)2025-12-31-$3.80Mn/m
Rocket One Inc. (RKTO)2025-12-31$6.15M-10.6%
Silo Pharma, Inc. (SILO)2025-12-31$6.31M+25.3%
Acurx Pharmaceuticals, Inc. (ACXP)2025-12-31$5.27M+756.5%
Ensysce Biosciences, Inc. (ENSC)2025-12-31$3.21M-13.3%
Processa Pharmaceuticals, Inc. (PCSA)2025-12-31$5.58M+228.8%
Telomir Pharmaceuticals, Inc. (TELO)2025-12-31$5.91M+819.6%
Dermata Therapeutics, Inc. (DRMA)2025-12-31$6.22M+298.7%
Matinas BioPharma Holdings, Inc. (MTNB)2025-12-31$4.83M-36.4%

Compare ONCY, RKTO, SILO, ACXP side by side · Screen every company in Pharmaceutical Preparations ↗